Isracann Biosciences Inc. IPOT.CN Stock
Isracann Biosciences Inc. Price Chart
Isracann Biosciences Inc. IPOT.CN Financial and Trading Overview
| Isracann Biosciences Inc. stock price | 0.02 CAD |
| Previous Close | 0.02 CAD |
| Open | 0 CAD |
| Bid | 0.01 CAD x N/A |
| Ask | 0.03 CAD x N/A |
| Day's Range | 0.02 - 0.02 CAD |
| 52 Week Range | 0.01 - 0.07 CAD |
| Volume | 0 CAD |
| Avg. Volume | 36.53K CAD |
| Market Cap | 2.64M CAD |
| Beta (5Y Monthly) | 0.021571 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
IPOT.CN Valuation Measures
| Enterprise Value | 2.44M CAD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 14.999999 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.114 |
Trading Information
Isracann Biosciences Inc. Stock Price History
| Beta (5Y Monthly) | 0.021571 |
| 52-Week Change | -72.72% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.07 CAD |
| 52 Week Low | 0.01 CAD |
| 50-Day Moving Average | 0.02 CAD |
| 200-Day Moving Average | 0.02 CAD |
IPOT.CN Share Statistics
| Avg. Volume (3 month) | 36.53K CAD |
| Avg. Daily Volume (10-Days) | 0 CAD |
| Shares Outstanding | 175.99M |
| Float | 175.69M |
| Short Ratio | 0.13 |
| % Held by Insiders | 0.17% |
| % Held by Institutions | 0% |
| Shares Short | 4.3K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:3 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | May 31, 2022 |
| Most Recent Quarter (mrq) | August 31, 2022 |
| Next Fiscal Year End | May 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -34.99% |
| Return on Equity (ttm) | -252.75% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -2188597 CAD |
| Net Income Avi to Common (ttm) | -4540223 CAD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 198.05K CAD |
| Total Cash Per Share (mrq) | 0.001 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.295 |
| Book Value Per Share (mrq) | 0.001 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1475229 CAD |
| Levered Free Cash Flow (ttm) | -567046 CAD |
Profile of Isracann Biosciences Inc.
| Country | Canada |
| State | BC |
| City | Vancouver |
| Address | 595 Burrard Street |
| ZIP | V7X 1L3 |
| Phone | 604-394-2551 |
| Website | https://www.isracann.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Isracann Biosciences Inc., together with its subsidiaries, cultivates and distributes medical cannabis in Israel. The company also develops cultivation facilities. It exports its products to Germany. The company was formerly known as Atlas Blockchain Group Inc. and changed its name to Isracann Biosciences Inc. in October 2019. Isracann Biosciences Inc. was founded in 2010 and is headquartered in Vancouver, Canada.
Q&A For Isracann Biosciences Inc. Stock
What is a current IPOT.CN stock price?
Isracann Biosciences Inc. IPOT.CN stock price today per share is 0.02 CAD.
How to purchase Isracann Biosciences Inc. stock?
You can buy IPOT.CN shares on the Canadian Sec exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Isracann Biosciences Inc.?
The stock symbol or ticker of Isracann Biosciences Inc. is IPOT.CN.
Which industry does the Isracann Biosciences Inc. company belong to?
The Isracann Biosciences Inc. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Isracann Biosciences Inc. have in circulation?
The max supply of Isracann Biosciences Inc. shares is 175.99M.
What is Isracann Biosciences Inc. Price to Earnings Ratio (PE Ratio)?
Isracann Biosciences Inc. PE Ratio is now.
What was Isracann Biosciences Inc. earnings per share over the trailing 12 months (TTM)?
Isracann Biosciences Inc. EPS is -0.03 CAD over the trailing 12 months.
Which sector does the Isracann Biosciences Inc. company belong to?
The Isracann Biosciences Inc. sector is Healthcare.